Healthtech funding in H2 2013
European Healthtech startup funding raised during H2 2013.
In H2 2013, 60 European Healthtech companies closed 62 funding rounds and raised €328M in equity funding (excluding debt and grants), up 11.4% versus H2 2012. Switzerland led by capital raised, and Bpifrance was the most active investor. Data as of 6 Nov 2026.
Equity funding
€328M
+11.4% vs H2 2012 · excl. debt & grants
Funding rounds
62
+63.2% vs H2 2012
Companies
60
Top country
Switzerland
Rank among sectors
#3
11.3% of sector funding
Top-10 round share
73.9%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H2 2013 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €31M | 9 |
| Aug | €32M | 9 |
| Sep | €78M | 14 |
| Oct | €100M | 13 |
| Nov | €77M | 13 |
| Dec | €10M | 4 |
Top countries
by € raisedHealthtech — top countries by capital, H2 2013 — interactive chart.
Data table
| Healthtech — top countries by capital, H2 2013 | |
|---|---|
| Switzerland | €106M |
| France | €80M |
| UK | €39M |
| Germany | €36M |
| Netherlands | €31M |
| Israel | €13M |
| Denmark | €8.2M |
| Belgium | €6.5M |
Stage mix
by € raisedHealthtech — stage mix, H2 2013 — interactive chart.
Data table
| Healthtech — stage mix, H2 2013 | |
|---|---|
| Series B | €113M |
| Growth/Late | €67M |
| Other | €66M |
| Series A | €36M |
| Series D+ | €30M |
| Seed | €8.3M |
| Early VC | €4.3M |
| Series C | €3.0M |
| Grant | €185k |
Top deals
largest disclosed rounds in H2 2013| Company | Stage | Date | Amount |
|---|---|---|---|
| Merus | Series B | Oct 2013 | €31M |
| Evotec | Growth/Late | Sep 2013 | €30M |
| Biocartis | Series D+ | Nov 2013 | €30M |
| ADC Therapeutics | Growth/Late | Oct 2013 | €30M |
| ObsEva | Series A | Aug 2013 | €26M |
| MISSION Therapeutics | Series B | Nov 2013 | €24M |
| WiThings | Series B | Jul 2013 | €23M |
| CeQur | Series B | Sep 2013 | €20M |
| Pixium Vision | Other | Nov 2013 | €15M |
| THERAVECTYS | Other | Oct 2013 | €15M |
| Morria Biopharmaceuticals | Other | Oct 2013 | €11M |
| Gecko Biomedical | Other | Dec 2013 | €9.9M |
| Simplee | Series B | Sep 2013 | €7.6M |
| Egalet | Growth/Late | Sep 2013 | €7.6M |
| Epigenomics AG | Other | Aug 2013 | €5.0M |
Top investors
most active in H2 2013, by deal count- Bpifrance4 deals
- Sofinnova Partners3 deals
- Capricorn Partners2 deals
- IDInvest Partners2 deals
- Reaktor2 deals
- Wayra2 deals
- 360 Capital Partners1 deals
- 83North1 deals
- Accelerace1 deals
- Amgen Ventures1 deals